Our previous phytochemical studies on the methanolic extract of the rhizome of Dioscorea cayenensis LAM.-HOLL led to the isolation of a new furostanol saponin.
. The high-resolution ESI mass spectrometry (HR-ESI-MS) (positive-ion mode) of 1 exhibited a pseudomolecular ion peak at m/z 1231.5697 [MϩNa] ϩ (Calcd 1231.5724), consistent with a molecular formula of C 57 H 92 O 27 Na. Its negativeion FAB-MS showed a quasimolecular ion peak at m/z 1207 [MϪH] Ϫ , indicating a molecular weight of 1208. Acid hydrolysis of 1 yielded glucose, rhamnose (TLC) and an aglycone which was identified as a furostanol-type steroid by comparison of the NMR data of 1 ( Table 1) with those of known spirostane-type steroids. [1] [2] [3] The comparison of NMR data of 1 with literature data allowed the identification of the aglycone as the previously reported (3b,25R)-20,22-seco-25-furost-5-en-20,22-dione-3,26-diol (aglycone of dioscoreside D), 2, 3) and the five sugar residues as two b-glucopyranosyl (Glc) and three a-rhamnopyranosyl (Rha) moieties. The absolute configurations of glucose and rhamnose were determined to be D and L, respectively, by GC analysis of chiral derivatives of the sugars in the acid hydrolysate (see experimental section). The Tables  1, 2 ) obtained from its 2D NMR spectra were almost superimposable with those of dioscoreside D, 3) except for the presence of an additional terminal a-L-rhamnopyranosyl moiety. The sequence of the four sugars at the C-3 position was indicated by long-range coupling ( 3 J) in the HMBC spectrum between Rha H-1 (dϭ6.10) and Glc I C-2 (dϭ78.0), Rha II H-1 (dϭ5.58) and Glc I C-4 (dϭ77.9) and Rha III H-1 (dϭ6.03) and Rha II C-4 (dϭ79.8). the basis of the above results, compound 1 was deduced to be (Fig. 1) , a new natural compound.
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Compounds 2-4 were identified by interpretation of their spectral data, mainly FAB-MS and 2D-NMR (COSY, TOCSY, NOESY, HSQC and HMBC), as well by comparison with literature data as methyl protodioscin (2), 5) asperoside (3), 6) and prosapogenin A of dioscin (4), 7) respectively. The antifungal activity of saponins 1-4 (Table 3 ) was evaluated at concentrations of less than 200 mg/ml against strains of Candida albicans, C. glabrata and C. tropicalis. Compound 1 presented MIC values above 200 mg/ml, and was considered inactive against the yeasts tested. Compounds 2-3, having a furostan skeleton, were also devoid of activity against the tested fungi. Compound 4, having a spirostan skeleton, presented antifungal activity against Candida species with MIC values between 6.25 and 25 mg/ml. Regarding the aglycone structure, we confirmed the presence of antifungal activity only with the spirostanol derivative, whereas none was observed with the furostanol derivatives. 1) This confirms that the E and F rings of diosgenin play a key role in the antifungal properties.
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Experimental
General Experimental Methods IR, FAB-MS, 2D-NMR (COSY, TOCSY, NOESY, HSQC and HMBC), medium-pressure liquid chromatography (MPLC) instruments and GC analysis were as previously described. 9) HR-ESI-MS was carried out on a Q-TOF 1-micromass spectrometer. Optical rotations were taken with a Perkin-Elmer 881 polarimeter. TLC and HPTLC were performed on silica gel plates 60 F 254 (Merck), using the following solvent systems: (a) for saponins CHCl 3 -MeOH-H 2 O (13 : 7 : 2; lower phase), (b) for sapogenins CHCl 3 -MeOH (9 : 1), and (c) for sugars Extraction and Separation Dried powdered rhizomes (800 g) of D. cayenensis were refluxed with MeOH-H 2 O (7 : 3, 6 l), and evaporated to dryness yielding 17.9 g of MeOH-H 2 O extract. This was partitioned successively with hexane, CH 2 Cl 2 and n-BuOH (each 3ϫ200 ml) yielding after evaporation of the solvents the corresponding hexane (2 g), CH 2 Cl 2 (1.3 g) and n-BuOH (7 g) fractions. 5 g of the n-BuOH residue was dissolved in MeOH and purified by precipitation with diethyl ether (3ϫ300 ml), yielding a crude saponin mixture (3.45 g). This latter was submitted to the vacuum liquid chromatography on C 18 reversed-phase (12ϫ3 cm) using H 2 O (100 ml), MeOH-H 2 O mixtures (5 : 5; 4 : 1, each 100 ml) and finally MeOH (100 ml). The fraction eluted with MeOH-H 2 O (4 : 1) was submitted to MPLC column chromatography (Si gel (15-40 mm), CHCl 3 -MeOH-H 2 O (13 : 7 : 2, lower phase)), yielding 7 fractions, 1-7. Fraction 2 was concentrated to dryness to give the pure compound 1 (8 mg). Fractions 4 and 7 were rechromatographed under the same conditions to give the pure compounds 2 (10 mg) and 3 (7 mg), respectively. The fraction eluted with 100% MeOH was submitted to an additional MPLC in the same conditions to give 6 fractions, 1-6. Fraction 2 was rechromatographed by using MPLC in the same conditions to give the pure compound 4 (7 mg).
26 Tables  1 and 2 .
Acid Hydrolysis A solution of compound 1 (3 mg) in 2 N aqueous CF 3 COOH (5 ml) was refluxed on a water bath for 3 h. After extraction with CH 2 Cl 2 (3ϫ5 ml), the aqueous layer was repeatedly evaporated to dryness with MeOH until neutral, and glucose was identified by TLC with a standard using CHCl 3 -MeOH-H 2 O (8 : 5 : 1). Furthermore, a silylated derivated of the sugar was prepared according to the procedure previously described.
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L-cysteine methyl ester hydrochloride (0.06 mol/l) and HMDS-TMCS (hexamethyldisilazane-trimethylchlorosilane, 3 : 1) were added to the aqueous residue. After centrifugation of the precipitate, the supernatant was concentrated and partitioned between n-hexane and H 2 O, and the hexane layer was analyzed by GC. D-Glucose and L-rhamnose were detected.
Antifungal Activity Minimum inhibitory concentrations (MICs) were performed using the broth dilution test. 10) For these bioassays, three human pathogenic yeasts were used: Candida albicans (IP 1180-79), C. glabrata and C. tropicalis (clinical isolates). The reference compound ketoconazole (Sigma) 11) was used as a positive control.
